The Order of Exposure to Cytotoxic Chemotherapy and the Proteasome Inhibitor Bortezomib Dictates the Extent of Reversal of Chemotherapy Resistance in T-ALL.
2012
https://researcherprofiles.org/profile/79296796
May Y. Szeto, Justin Wahlstrom, Michelle L. Hermiston
